Rafael Holdings RFL
NYSE RFL
$1.50 +0.18 (+13.64%)
As of: Oct 1, 2026 · 3:59 PM EDT

Rafael Holdings (RFL) Net Margin (2017 - 2026)

Updated

Rafael Holdings (RFL) reported Net Margin of -2360.89% for fiscal Q3 2026 (quarter ended Apr 30, 2026), down 1040.73 percentage points from -1320.17% a year earlier but up 680.34 percentage points from the prior quarter.

Analysis

Rafael Holdings (RFL) Net Margin (2017 - 2026) Analysis & Trends

Over the twelve months ended Apr 30, 2026, Rafael Holdings' Net Margin came in at -2117.24%, up 1010.35 percentage points year-over-year; for FY2025 (ended Jul 31, 2025), it came in at -3328.24%, up 2073.64 percentage points from FY2024.

  • Net Margin has a five-year change of -3109.24 percentage points (FY2020 to FY2025).
  • By fiscal year, Net Margin came in at -5401.88% in FY2024 (-4729.48 pp), -672.40% in FY2023 (+29731.99 pp), -30404.39% in FY2022 (-27344.04 pp) and -3060.35% in FY2021 (-2841.35 pp).
  • Five-year quarterly Net Margin spans a low of -58651.31% in fiscal Q1 2022 and a high of 8892.65% in fiscal Q2 2024.
  • Year over year, Net Margin gained in four of the last eight quarters, with an average year-over-year change of -660.25 percentage points.
  • The high point for year-over-year Net Margin in five years was fiscal Q1 2023 (a gain of 60925.59 percentage points); the low point was fiscal Q1 2022 (a drop of 58513.99 percentage points).
  • Per Business Quant data, the three fiscal quarters before Q3 2026 came in at -3041.23% (Q2 2026), -4090.00% (Q1 2026) and -82.86% (Q4 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Margin (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 21.86%
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 21.27%
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn -8.04%
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 22.61%
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 18.81%
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 23.62%
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn -134.51%
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -1.65%
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 32.99%
10 Rafael Holdings 68.10 Mn 73.52 Mn 163,000.00 -2,360.89%
Historic Data

Historic Data

Download Data
DateValue
Apr 30, 2026 -2,360.89%
Jan 31, 2026 -3,041.23%
Oct 31, 2025 -4,090.00%
Jul 31, 2025 -82.86%
Apr 30, 2025 -1,320.17%
Jan 31, 2025 -6,027.27%
Oct 31, 2024 -7,035.94%
Jul 31, 2024 -2,707.88%
Apr 30, 2024 -9,628.27%
Jan 31, 2024 8,892.65%
Oct 31, 2023 -5,350.00%
Jul 31, 2023 1,792.65%
Apr 30, 2023 -2,023.94%
Jan 31, 2023 -4,642.86%
Oct 31, 2022 2,274.29%
Jul 31, 2022 -6,933.33%
Apr 30, 2022 -7,275.00%
Jan 31, 2022 -3,136.49%
Oct 31, 2021 -58,651.31%
Apr 30, 2021 -257.88%
API Access

Rafael Holdings Net Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=net-margin&ticker=RFL&period=max&api_key=YOUR_API_KEY